The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 1)
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Boston Children's Hospital
- Study ID
- NCT07303738
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Aspiration
- Feeding Difficulties
- Gastrostomy
Eligibility Criteria
- Sex
- ALL
- Age
- 5 Years - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- amino acid based formula (e.g. Elecare Jr) — DRUGWe will administer one bolus of an amino acid based formula
- low bile acid binding blenderized diet (e.g. Kate Farms) — DRUGWe will administer one bolus of a low bile acid binding blenderized diet
- high bile acid binding blenderized diet — DRUGWe will administer one bolus of a high bile acid binding blenderized diet
Study Details
We will perform an acute physiology study comparing three different diets-an amino acid-based formula, a low bile acid-binding blenderized diet, or a high bile acid-binding blenderized diet administered through gastrostomy tube. We will determine the differences in gastric and salivary bile acid concentrations between participants over the 4 hour post-prandial timeframe. Participants who regularly receive an amino acid-based formula will receive an amino acid-based formula during the study and participants who regularly receive a blenderized feed will receive a blenderized feed during the study. Only participants who regularly receive blenderized feeds will be randomized to receive either the high or low bile acid binding blenderized feed.
Key Dates
- Start date
- Dec 1, 2025
- Status verified
- Mar 2025
- Primary completion
- Aug 31, 2030
- Completion
- Aug 31, 2030
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Active Comparator: amino acid-based formula (e.g., elecare, neocate)
- Active Comparator: low bile acid binding blenderized diet (e.g., real food blends)
- Experimental: high bile acid binding blenderized diet (proprietary)
Primary Outcome Measure
Gastric bile acid concentration [ Time Frame: 4 hours ]
Central Contacts
- Rachel Rosen617-355-0897
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Children's Hospital | Boston | Massachusetts | 02115 | - |
Find similar trials in Boston, MA
Related Studies
- Effect of Thickened Feeds on Swallow Physiology in Children With DysphagiaRecruiting · Boston Children's Hospital · Boston, Massachusetts
- Aspiration in Acute Respiratory Failure Survivors 2Recruiting · University of Colorado, Denver · Stanford, California
- Feasibility of a Constant Pressure Skin Disk (CPSD) in Enteral Tubes.Recruiting · Mayo Clinic · Rochester, Minnesota
- RCT: Early Feeding After PEG PlacementRecruiting · Carilion Clinic · Roanoke, Virginia